β¨ Medicines Notices
10 JUNE 2010
NEW ZEALAND GAZETTE, No. 64
1855
Product:
Fluconazole
Active Ingredient: Fluconazole 2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare of Puerto Rico, Jayuya, Puerto Rico
Product:
Jurnista
Active Ingredient: Hydromorphone hydrochloride 4mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alza Corporation, Vacaville, United States of America
Product:
Sensodyne Pronamel
Active Ingredients: Potassium nitrate 50mg/g
Sodium fluoride 2.21mg/g
Dosage Form: Toothpaste
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Dated this 3rd day of June 2010.
STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go4427
Renewal of Provisional Consent to the Distribution of Medicines
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product:
Bicillin L-A
Active Ingredient: Benzathine benzylpenicillin tetrahydrate 450mg/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers: Wyeth Pharmaceuticals Inc, West Chester, United States of America
King Pharmaceuticals Inc, Rochester, United States of America
Note: This renewed consent is valid for two years from 7 August 2010.
Product:
Potassium 10mmol
Active Ingredient: Potassium chloride 7.385g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Pty Limited, Old Toongabbie, Australia
Note: This renewed consent is valid for two years from 12 June 2010.
Product:
Potassium 40mmol
Active Ingredient: Potassium chloride 2.95g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Pty Limited, Old Toongabbie, Australia
Note: This renewed consent is valid for two years from 12 June 2010.
Dated this 3rd day of June 2010.
STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).
go4430
Misuse of Drugs Act 1975
Capital Coast District Health Boardβs Opioid Treatment Service
Places at Which Controlled Drugs May be Prescribed, Administered, or Supplied for the Purpose of Treating People with Drug Dependence
Pursuant to section 24(7)(b) of the Misuse of Drugs Act 1975, the places at which controlled drugs may be prescribed, administered, or supplied for the purposes of that section, subject to the agreed conditions.
DAVID CHAPLOW (DR), Director of Mental Health, acting under delegated authority from the Minister of Health, specify that the places operated by
Dated at Wellington this 27th day of May 2010.
go4259
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare3 June 2010
Medicines Act, Consent, Fluconazole, Jurnista, Sensodyne Pronamel
- STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
π₯ Renewal of Provisional Consent to Distribution of Medicines
π₯ Health & Social Welfare3 June 2010
Medicines Act, Renewal, Bicillin L-A, Potassium 10mmol, Potassium 40mmol
- STEWART JESSAMINE, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
π₯ Places for Controlled Drugs Prescription and Administration
π₯ Health & Social Welfare27 May 2010
Misuse of Drugs Act, Opioid Treatment, Controlled Drugs
- DAVID CHAPLOW (DR), Director of Mental Health
NZ Gazette 2010, No 64